PHAT logo

PHAT

Profile

Full Name

Phathom Pharmaceuticals, Inc.

Ticker Symbol

NASDAQ: PHAT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 25, 2019

Indexes

Not included

Website

http://www.phathompharma.com

Employees

427

Key Details

Price

$8.92(+0.11%)

Market cap

$622.74M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$55.25M(+8001.47% YoY)

Annual EPS

-$5.29(-34.61% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.92
    PHAT price is $8.92

    30-Day Relative Volume

    0.14
    PHAT 30-day relative volume is 0.14

    Price Performance

    Price Most recent change

    +0.11%
    PHAT price was up +0.11% on Jul 3, 2025

    Price YTD change

    +9.85%
    PHAT price is up +9.85% since January 1st

    Price 1-year change

    -12.98%
    PHAT price is down -12.98% year-on-year

    Price 3-year change

    -1.65%
    PHAT price is down -1.65% over the past 3 years

    Price Range

    Price All-time high

    $64.54
    PHAT price is currently -86.18% below its historical high of $64.54

    Price 3-year low

    $2.21
    PHAT price is currently +303.62% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $622.74M
    PHAT market capitalization is $622.74 million

    Market cap 3-year change

    +78.93%
    PHAT market capitalization is up +78.93% over the past 3 years

    Market cap All-time high

    $1.39B
    PHAT market capitalization is currently -55.14% below its historical high of $1.39 billion

    Market cap sector rank

    70.3%
    PHAT market capitalization is higher than 70.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +19.13%
    PHAT shares outstanding is up +19.13% year-on-year

    Shares Outstanding 3-Year Change

    +81.94%
    PHAT shares outstanding is up +81.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.36
    PHAT beta is 1.36

    200-day SMA

    $8.63
    PHAT price is currently +3.34% above its 200-day simple moving average

    50-day SMA

    $6.02
    PHAT price is currently +48.09% above its 50-day simple moving average

    RSI

    57.38
    PHAT 14-day relative strength index is 57.38

    Volume

    0.14
    PHAT 30-day relative volume is 0.14

    ATR

    $0.78
    PHAT average true range is $0.78

    10-day Historical Volatility

    63.79%
    PHAT 10-day historical volatility is 63.79%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $55.25M
    PHAT annual revenue is $55.25 million

    Revenue Analysts estimate

    $159.60M
    PHAT annual revenue is currently -65.38% lower than the consensus analysts' forecast

    Revenue 1-year change

    +8001.47%
    PHAT annual revenue is up +8001.47% year-on-year

    Revenue Sector rank

    48.19%
    PHAT annual revenue is higher than 48.19% of companies in Healthcare sector

    EPS

    EPS

    -$5.29
    PHAT annual earnings per share is -$5.29

    EPS Analysts estimate

    -$2.93
    PHAT annual earnings per share is currently +80.70% higher than the consensus analysts' forecast

    EPS 1-year change

    -34.61%
    PHAT annual earnings per share is down -34.61% year-on-year

    EPS Sector rank

    19.22%
    PHAT annual earnings per share is higher than 19.22% of companies in Healthcare sector

    Profit

    Gross profit

    $47.28M
    PHAT annual gross profit is $47.28 million

    Gross margin

    85.57%
    PHAT annual gross profit margin is 85.57%

    Operating profit

    -$277.47M
    PHAT annual operating income is -$277.47 million

    Operating margin

    -502.18%
    PHAT annual operating profit margin is -502.18%

    Net income

    -$334.33M
    PHAT annual net profit is -$334.33 million

    Net margin

    -605.09%
    PHAT annual net profit margin is -605.09%

    Expenses

    Total expenses

    $332.72M
    PHAT annual total expenses is $332.72 million

    Operating expenses

    $324.75M
    PHAT annual total operating expenses is $324.75 million

    Cost of goods sold

    $7.97M
    PHAT annual cost of goods sold is $7.97 million

    Selling, general & administrative expenses

    $290.66M
    PHAT annual SGA is $290.66 million

    Depreciation and amortization

    $795.00K
    PHAT annual depreciation & amortization is $795.00 thousand

    Interest expense

    $72.01M
    PHAT annual interest expense is $72.01 million

    Income tax

    -
    PHAT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$262.32M
    PHAT annual earnings before interest & taxes is -$262.32 million

    EBITDA

    -$261.52M
    PHAT annual EBITDA is -$261.52 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $378.32M
    PHAT annual total assets is $378.32 million

    Non current assets

    $18.18M
    PHAT annual long term assets is $18.18 million

    Current assets

    $360.13M
    PHAT annual total current assets is $360.13 million

    Cash and cash equivalents

    $297.26M
    PHAT annual cash & cash equivalents is $297.26 million

    Accounts receivable

    $38.80M
    PHAT annual accounts receivable is $38.80 million

    Inventory

    $3.21M
    PHAT annual inventory is $3.21 million

    Liabilities

    Total liabilities

    $631.90M
    PHAT annual total liabilities is $631.90 million

    Long term liabilities

    $546.17M
    PHAT annual total long term liabilities is $546.17 million

    Current liabilities

    $85.73M
    PHAT annual total current liabilities is $85.73 million

    Accounts payable

    $10.51M
    PHAT annual accounts payable is $10.51 million

    Debt

    Total debt

    $201.91M
    PHAT annual total debt is $201.91 million

    Total debt 1-year change

    +45.23%
    PHAT annual total debt is up +45.23% year-on-year

    Long term debt

    $201.41M
    PHAT annual long term debt is $201.41 million

    Short term debt

    $501.00K
    PHAT annual short term debt is $501.00 thousand

    Equity & Capital

    Shareholders equity

    -$253.58M
    PHAT annual stockholders equity is -$253.58 million

    Book value

    -$253.58M
    PHAT annual book value is -$253.58 million

    Retained earnings

    -$1.26B
    PHAT annual retained earnings is -$1.26 billion

    Working capital

    $274.41M
    PHAT annual working capital is $274.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$266.77M
    PHAT annual cash flow from operations is -$266.77 million

    Cash from operations 1-year change

    -93.9%
    PHAT annual cash flow from operations is down -93.9% year-on-year

    Cash from investing

    -$135.00K
    PHAT annual cash flow from investing activities is -$135.00 thousand

    Cash from investing 1-year change

    +91.74%
    PHAT annual cash flow from investing activities is up +91.74% year-on-year

    Cash from financing

    $182.77M
    PHAT annual cash flow from financing activities is $182.77 million

    Cash from financing 1-year change

    -50.28%
    PHAT annual cash flow from financing activities is down -50.28% year-on-year

    CAPEX

    CAPEX

    $135.00K
    PHAT annual capital expenditures is $135.00 thousand

    CAPEX 1-year change

    -91.74%
    PHAT annual capital expenditures is down -91.74% year-on-year

    Free Cash Flow

    Free cash flow

    -$266.90M
    PHAT annual free cash flow is -$266.90 million

    Free cash flow 1-year change

    -91.72%
    PHAT annual free cash flow is down -91.72% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    85.57%
    PHAT annual gross profit margin is 85.57%

    Operating margin

    -502.18%
    PHAT annual operating profit margin is -502.18%

    Net margin

    -605.09%
    PHAT annual net profit margin is -605.09%

    ROA & ROE

    ROA

    -84.41%
    PHAT annual return on assets is -84.41%

    ROE

    131.84%
    PHAT annual return on equity is 131.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    PHAT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    PHAT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -1.84
    PHAT price to book ratio is -1.84

    PB ratio Sector rank

    8.21%
    PHAT price to book ratio is higher than 8.21% of companies in Healthcare sector

    PS Ratio

    PS ratio

    7.61
    PHAT price to sales ratio is 7.61

    PS ratio Sector rank

    72.55%
    PHAT price to sales ratio is higher than 72.55% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $613.99M
    PHAT enterprise value is $613.99 million

    Enterprise value Sector rank

    69.4%
    PHAT enterprise value is higher than 69.4% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.26
    PHAT EV/EBITDA is -2.26

    EV/EBITDA Sector rank

    36.59%
    PHAT EV/EBITDA is higher than 36.59% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.20
    PHAT annual current ratio is 4.20

    Quick ratio

    4.16
    PHAT annual quick ratio is 4.16

    Leverage

    Debt to equity

    -0.79
    PHAT annual debt to equity ratio is -0.79

    Interest coverage ratio

    -3.64
    PHAT annual interest coverage ratio is -3.64

    Risk & Stability

    Piotroski F-Score

    3
    PHAT piotroski f-score is 3

    Altman Z-Score

    -5.35
    PHAT altman z-score is -5.35

    Analyst ratings

    Recent major analysts updates

    Jun 9, 25 HC Wainwright & Co.
    Buy
    Jun 9, 25 Craig-Hallum
    Buy
    Jun 6, 25 Needham
    Buy
    May 2, 25 HC Wainwright & Co.
    Buy
    May 2, 25 Guggenheim
    Buy
    May 2, 25 Goldman Sachs
    Neutral
    May 2, 25 Craig-Hallum
    Buy
    Apr 21, 25 Needham
    Buy
    Apr 17, 25 Goldman Sachs
    Neutral
    Apr 9, 25 Needham
    Buy

    Institutional Ownership

    Screeners with PHAT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Phathom Pharmaceuticals, Inc.?
    • Does Phathom Pharmaceuticals, Inc. pay dividends?
    • What sector is Phathom Pharmaceuticals, Inc. in?
    • What industry is Phathom Pharmaceuticals, Inc. in?
    • What country is Phathom Pharmaceuticals, Inc. based in?
    • When did Phathom Pharmaceuticals, Inc. go public?
    • Is Phathom Pharmaceuticals, Inc. in the S&P 500?
    • Is Phathom Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Phathom Pharmaceuticals, Inc. in the Dow Jones?
    • When was Phathom Pharmaceuticals, Inc.'s last earnings report?
    • When does Phathom Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Phathom Pharmaceuticals, Inc.?

    The ticker symbol for Phathom Pharmaceuticals, Inc. is NASDAQ:PHAT

    Does Phathom Pharmaceuticals, Inc. pay dividends?

    No, Phathom Pharmaceuticals, Inc. does not pay dividends

    What sector is Phathom Pharmaceuticals, Inc. in?

    Phathom Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Phathom Pharmaceuticals, Inc. in?

    Phathom Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Phathom Pharmaceuticals, Inc. based in?

    Phathom Pharmaceuticals, Inc. is headquartered in United States

    When did Phathom Pharmaceuticals, Inc. go public?

    Phathom Pharmaceuticals, Inc.'s initial public offering (IPO) was on October 25, 2019

    Is Phathom Pharmaceuticals, Inc. in the S&P 500?

    No, Phathom Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Phathom Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Phathom Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Phathom Pharmaceuticals, Inc. in the Dow Jones?

    No, Phathom Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Phathom Pharmaceuticals, Inc.'s last earnings report?

    Phathom Pharmaceuticals, Inc.'s most recent earnings report was on May 1, 2025

    When does Phathom Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Phathom Pharmaceuticals, Inc. is August 8, 2025
    On this page